Top executives from the bioMérieux Group visited Deere.


Release Date:

2014-09-17

On September 17, 2014, Mr. Richard Ding, Corporate Vice President for the Asia Pacific Region at bioMérieux, paid a visit to Dier. With a history spanning over a century, bioMérieux is a globally renowned leader in the field of microbiology and one of the world’s major players in in vitro diagnostics. The Asia Pacific region is a strategic priority for its growth, and since entering China in the 1980s, the company has been committed to strengthening exchanges and collaboration with China’s microbiological community. Dier was among the first in China to enter the clinical microbiology field…

2014 9 month 17 Day, bioMérieux (BIOMERIEUX) Group Vice President responsible for the Asia-Pacific region (Corporate VP, Asia Pacific Region), Mr. Richard Ding paid a visit to Deere.

With a century-long history, bioMérieux is a globally renowned company in the field of microbiology and one of the world’s leading players in in vitro diagnostics, serving the Asia-Pacific region. The region is a strategic priority for its development, since the last century… 80 Since its entry into China, it has been committed to strengthening exchanges and cooperation with the Chinese microbiological community.

Dier is a leading Chinese domestic enterprise that was among the first to enter the clinical microbiology field. Dier has consistently pursued a path of self-reliance and independent R&D, and its products… It is well-suited to China’s national conditions and meets the needs of hospitals at all levels. Since entering the international market last year, after more than six months of development, it has already… The company has made significant strides in overseas markets, securing a prominent position for China’s clinical microbiology diagnostic and testing products on the global stage.

One of the two companies From the world’s spotlight on China, a Start From China Going global, through mutual communication and learning from one another, we will leverage our strengths and make up for our weaknesses, thereby achieving shared… Similarly, by striving to increase the share of clinical microbiology testing within the in vitro diagnostics field, we will undoubtedly enhance its standing in evidence-based medicine. Enhancement.